BISMORE@EC2606A

EVE Energy's Investment in Smoore Rescued by Minority Shareholders and Generated Huge Profits

Smooer International Reports Unaudited Financial Data for September 2025

Smoll International Renews Procurement Agreement with Ewatt Lithium

EVE Energy and Smoore Sign Procurement Framework Agreement for Battery Cells

Smoot International Subscribes to Morgan Stanley's Bills for HKD 624 million

Smootheerm International Subscribes to Morgan Stanley Bonds

Huachuang Securities Adjusts Smoore International's Earnings Forecast

GuoTaiHaitong Upgrades Smoore's Profit Forecast to 110x PE in 2025

Smoothee International Reports Record High Q3 25 Revenue, Huatai Securities Maintains Buy Rating

CICC Maintains Overweight Rating on Smoore International

Smoothe International Reports Q3 Earnings and Subsidiary TranspireBio's ANDA Application Accepted by FDA

Smooer International's Q3 Profit Decreased Despite 27% Revenue Growth

SMOORE INTL released FY2025 9 Months earnings on October 12 (BJT), actual revenue HKD 11.1 B, actual EPS HKD 0.1421

SMOORE INTL released FY2025 Q3 earnings on October 12, 2025 (BJT) with actual revenue of HKD 4.588 B and EPS of HKD 0.0559

Smoller International's Q3 2025 Revenue Hits New High

UBS Maintains Sell Rating on Smoore, Forecasts 2025 Net Profit Decline

VAPORESSO Launches XROS 5 and XROS 5 MINI Special Editions

Smoothe International Holdings Has a High Proportion of Internal Shareholding

Smoothe International's Net Profit Down in H1, CLSA Maintains 'Outperform' Rating Despite Lowering Target Price

Smoothe Launches Premium HNB Product, Revenue Rebounds

DAISHOMICROLINE

PUTIAN COMM

MOBI DEV

NANFANG COMM

ADD NEW ENERGY

ELIFE HLDGS

SIWI SCI & TECH

DTXS SILK ROAD

SANDMARTIN INTL

HAO BAI INTL

002191

06969

300457

China's State Tobacco Monopoly Administration has ordered e-cigarette manufacturers to halt the construction of new production plants to address overcapacity and curb price wars in the industry. The notice emphasizes that new investments should only be made if necessary and for the purpose of exporting e-cigarettes. It prohibits shifting supply quotas to unlicensed companies and expanding capacity under the guise of producing other products. E-cigarette makers may reorganize production through mergers, and production lines must be clearly distinguished from those for heated cigarettes and smoking utensils.

Reuters

JINJIA

SMOORE INTL

RLX Tech

YINGHE TECHNOLOGY

China regulator orders e-cigarette makers to halt new plants

09987

01797

06681

06938

00565

01873

03933

00596

09896

YUM CHINA(09987) rose 11.42%, with a trading turnover 1.1 Billion HKD, and a year-to-date rose 18.6%. EAST BUY(01797) rose 10.68%, with a trading turnover 1.2 Billion HKD, and a year-to-date rose 76.9%. BRAINAURORA-B(06681) rose 10.6%, with a trading turnover 647.3 Million HKD, and a year-to-date fell 25.5%.

Top Gainers & Losers

YUM CHINA

EAST BUY

BRAINAURORA-B

RIBOLIFE-B

ART GROUP HOLD

VIVA BIOTECH

UNITED LAB

INSPUR DIGI ENT

MNSO

Top 10 HK Stock Gainers (2.5)

SMOORE INTL (6969.HK) hit a new phase low on January 14, with trading sentiment remaining persistently low. The company is constrained by expectations of tightened regulation and an overall bearish atmosphere in the global market, lacking new buying momentum recently. There are currently no marginally positive policies in the industry, and major funds within the sector continue to test lower support levels, leading to a heavy wait-and-see sentiment among new funds, resulting in narrow and persistently low daily fluctuations. In terms of technical trends, the MACD remains in negative territory, and the bullish arrangement of the moving average system has not yet formed, with daily K-line momentum weak and significant short-term downward pressure. There are occasional low-level rebounds during the trading session, but the volume is difficult to sustain each time. The market is highly focused on the support level of HKD 11.18, with buying from speculative players each time it is reached, but the elasticity is limited and frequently fluctuates. If no positive factors emerge in the news, the stock is expected to likely maintain a low-level oscillation stalemate. If there is a substantial warming of industry policies, a short-term rebound window may arise, but caution is needed regarding the strength and sustainability of the rebound. Overall, the operational suggestion emphasizes risk prevention, with conservative investors advised to wait and pay attention to the pace of gradual accumulation; aggressive investors should closely track changes in sector fund flows and significant marginal policy news to seize sudden reversal opportunities

Technical Forecast

Morning Trend | SMOORE falls to a low volatility zone, can new funds activate a rebound?

Smoore International Holdings Ltd. has granted 545,000 awarded shares to seven employees under its amended share award scheme. The awarded shares will vest and allow recipients to receive company shares. After this grant, 305,883,671 shares remain available for future grants under the scheme.

Smoore International Grants 545,000 Awarded Shares to Employees

Smoore International Holdings Ltd. has filed an updated list of directors with the Hong Kong Stock Exchange. The board includes Executive Directors Mr. Chen Zhiping, Mr. Xiong Shaoming, Mr. Wang Guisheng, and Ms. Wang Xin; Non-Executive Director Ms. Jiang Min; and Independent Non-Executive Directors Mr. Zhong Shan, Mr. Yim Siu Wing, Simon, and Dr. Wang Gao. Various committees are chaired by these directors, with specific roles outlined for each. This filing is for informational purposes and not financial advice.

Smoore International Files Director List to HKEX

Smoore International Holdings Ltd. has appointed Zhong Shan as Lead Independent Director and added Wang Xin and Yim Siu Wing, Simon to its Nomination Committee, effective December 24, 2025. This announcement was made via the Hong Kong Stock Exchange's Issuer Information Service.

Smoore International Appoints Zhong Shan as Lead Independent Director and Adds Two to Nomination Committee

Smoore International Trustee Buys Back Nearly 8 Million Shares Under Incentive Scheme

marketscreener

Smoore International Trustee Buys Back Nearly 8 Million Shares Under Incentive Scheme

Smoore International Holdings Limited announced the purchase of 7,991,000 shares on 12 December 2025 for its Share Award Plan at an average price of HK$12.4835 each, totaling about HK$99.8 million. The Trustee now holds 95,741,030 shares, representing approximately 1.5457% of the company’s total shares. The Share Award Plan was first adopted in September 2021 and amended in February 2025.

Smoore International Launches Share Purchase Under Amended Award Plan

Smoore International Trustee Purchases Over 8 Million Shares Under Award Scheme

Smoore International Trustee Purchases Over 8 Million Shares Under Award Scheme

Smoore International Holdings Limited announced a share purchase under its Share Award Plan, acquiring 8,140,000 shares at an average price of approximately HK$12.2564, totaling around HK$99,766,880. This increases the total shares held by the Trustee to 87,750,030. The latest analyst rating on the stock is a Hold with a HK$11.50 price target.

Tip Ranks

Smoore International Expands Share Award Plan with New Purchase

01860

02575

02659

08030

00259

00667

02208

00800

01072

MOBVISTA(01860) rose 14.76%, with a trading turnover 647.9 Million HKD, and a year-to-date rose 96.8%. XUANZHUBIO-B(02575) rose 14.16%, with a trading turnover 47.2 Million HKD, and a year-to-date rose 567.2%. BAO PHARMA-B(02659) rose 9.52%, with a trading turnover 144.5 Million HKD, and a year-to-date rose 161.6%.

MOBVISTA

XUANZHUBIO-B

BAO PHARMA-B

FENGYINHE

YEEBO (INT'L H)

CHINA EAST EDU

GOLDWIND

WERIDE-W

DONGFANG ELEC

Top 10 HK Stock Gainers (12.11)

02582

02315

00108

01302

02522

01709

01931

00136

02343

GUOFUHEE(02582) fell 12.92%, with a trading turnover 301.3 Million HKD, and a year-to-date fell 73%. BIOCYTOGEN-B(02315) fell 11.52%, with a trading turnover 114.1 Million HKD, and a year-to-date rose 243.5%. GR LIFE STYLE(00108) fell 11.47%, with a trading turnover 16.4 Million HKD, and a year-to-date rose 320.3%.

GUOFUHEE

BIOCYTOGEN-B

GR LIFE STYLE

LIFETECH SCI

RIMAG GROUP

DL HOLDINGS GP

ETHK LABS INC.

CHINA RUYI

PACIFIC BASIN

Top 10 HK Stock Losers (12.10)

Smoore International Holdings Ltd. reported RMB 21.8 billion in net assets as of September 2025, based on unaudited accounts. Current assets were RMB 15,081.47 million, non-current assets RMB 12,938.09 million, current liabilities RMB 5,681.36 million, and non-current liabilities RMB 547.49 million. Equity attributable to shareholders was RMB 21,766.68 million. The figures are unaudited and may not reflect full-year performance.

Smoore International Reports RMB 21.8 Billion Net Assets as of September 2025

Smoore International Holdings Limited has renewed its Procurement Framework Agreement with EVE Energy, effective from January 1, 2026, to December 31, 2028. The agreement ensures the continued supply of battery products with annual caps set at RMB 580,000,000. This renewal supports Smoore’s operations in the global atomization and vaping markets. The latest analyst rating for Smoore's stock (HK:6969) is a Hold with a HK$14.00 price target.

Smoore International Renews Procurement Agreement with EVE Energy

BISMORE@EC2606A(24262.HK)

China regulator orders e-cigarette makers to halt new plants

Top 10 HK Stock Gainers (2.5)

Morning Trend | SMOORE falls to a low volatility zone, can new funds activate a rebound?

Smoore International Grants 545,000 Awarded Shares to Employees

Smoore International Files Director List to HKEX